Clearside Biomedical, Inc. (CLSDQ): going-concern / distress — Clearside Biomedical bankruptcy court approves sale process; Health Ocean Limited as stalking horse

Clearside Biomedical, Inc.

Court approved bidding procedures on Dec 19, 2025; Health Ocean Limited designated as stalking horse bidder.
Monthly operating report: $3.05M cash; net loss of $490,885 for seven days ending Nov 30, 2025.
Total assets negative $24.4M, equity negative $26.9M; prepetition unsecured debt $2.3M.
No employee payroll; no professional fees paid during period; court authorized tax payments.
Sale process subject to higher or better offers; auction to follow bidding procedures.

item 1.03 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

Clearside Biomedical, Inc. entered chapter 11 in United States Court for the District of Delaware.

Proceeding: chapter 11
Court: United States Court for the District of Delaware

Exact text from the filing

the Company filed a voluntary petition (Case No. 25-12109) for relief under Chapter 11 of the Bankruptcy Code in the United States Court for the District of Delaware

View on SEC.gov

Browse all distress & bankruptcy →

Clearside Biomedical, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-332152

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.